Results 361 to 370 of about 2,182,415 (399)
A global survey of potential acceptance of a COVID-19 vaccine
Nature Medicine, 2020 Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine.
Jeffrey V Lazarus +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.
New England Journal of Medicine, 2023BACKGROUND Respiratory syncytial virus (RSV) infection causes considerable illness in older adults. The efficacy and safety of an investigational bivalent RSV prefusion F protein-based (RSVpreF) vaccine in this population are unknown.
E. Walsh +30 more
semanticscholar +1 more source
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness
Nature, 2020 A vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is needed to control the coronavirus disease 2019 (COVID-19) global pandemic.
Kizzmekia S Corbett +2 more
exaly +2 more sources
Vaccines, vaccination in Brucellosis
Annales de l'Institut Pasteur / Microbiologie, 1987International ...
Plommet, Michel +2 more
openaire +3 more sources
Footrot vaccines and vaccination
Vaccine, 2014Research on footrot in small ruminants, which is caused by Dichelobacter nodosus, has led to development of vaccines and their application for control, treatment and eradication of the disease in sheep. Footrot vaccines have evolved over decades to contain monovalent whole cell, multivalent recombinant fimbrial, and finally mono or bivalent recombinant
Om, Dhungyel +2 more
openaire +2 more sources
New England Journal of Medicine, 2001
More than 70 bacteria, viruses, parasites, and fungi are serious human pathogens.1 Vaccines are available against some of these agents and are being developed against almost all the other bacteria and viruses and about half of the parasites. Table 1 lists infections for which there are now licensed vaccines and those for which a candidate vaccine has ...
openaire +2 more sources
More than 70 bacteria, viruses, parasites, and fungi are serious human pathogens.1 Vaccines are available against some of these agents and are being developed against almost all the other bacteria and viruses and about half of the parasites. Table 1 lists infections for which there are now licensed vaccines and those for which a candidate vaccine has ...
openaire +2 more sources
Current Opinion in Immunology, 1990
Much progress has been made towards reaching an understanding of immune responses at the molecular level. This has provided much needed information for identifying the antigens which will afford protection against diseases such as rabies, malaria, whooping cough, hepatitis and acquired immune deficiency syndrome, and for presenting them to the immune ...
openaire +3 more sources
Much progress has been made towards reaching an understanding of immune responses at the molecular level. This has provided much needed information for identifying the antigens which will afford protection against diseases such as rabies, malaria, whooping cough, hepatitis and acquired immune deficiency syndrome, and for presenting them to the immune ...
openaire +3 more sources
Influenza — to vaccinate or not to vaccinate?
Medical Journal of Australia, 1987openaire +2 more sources